Literature DB >> 32573056

Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications.

Yutaka Kurebayashi1,2, Naoto Kubota1, Michiie Sakamoto1.   

Abstract

Tumor tissue is composed of tumor cells and tumor stroma. Tumor stroma contains various immune cells and non-immune stromal cells, forming a complex tumor microenvironment which plays pivotal roles in regulating tumor growth. Recent successes in immunotherapies against tumors, including immune checkpoint inhibitors, have further raised interests in the immune microenvironment of liver carcinoma. The immune microenvironment of tumors is formed because of interactions among tumor cells, immune cells and non-immune stromal cells, including fibroblasts and endothelial cells. Different patterns of immune microenvironment are observed among different tumor subtypes, and their clinicopathological significance and intertumor/intratumor heterogeneity are being intensively studied. Here, we review the immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma, focusing on its histopathological appearance, clinicopathological significance, and relationship with histological and molecular classifications. Understanding the comprehensive histopathological picture of a tumor immune microenvironment, in addition to molecular and genetic approaches, will further potentiate the effort for precision medicine in the era of tumor-targeting immunotherapy.
© 2020 The Japan Society of Hepatology.

Entities:  

Keywords:  cholangiocarcinoma; hepatocellular carcinoma; liver metastasis; pathology; tumor immunology; tumor microenvironment

Year:  2020        PMID: 32573056     DOI: 10.1111/hepr.13539

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  9 in total

Review 1.  Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Authors:  Emily Latacz; Diederik Höppener; Ali Bohlok; Vincent Donckier; Peter M Siegel; Raymond Barnhill; Marco Gerling; Cornelis Verhoef; Peter B Vermeulen; Sophia Leduc; Sébastien Tabariès; Carlos Fernández Moro; Claire Lugassy; Hanna Nyström; Béla Bozóky; Giuseppe Floris; Natalie Geyer; Pnina Brodt; Laura Llado; Laura Van Mileghem; Maxim De Schepper; Ali W Majeed; Anthoula Lazaris; Piet Dirix; Qianni Zhang; Stéphanie K Petrillo; Sophie Vankerckhove; Ines Joye; Yannick Meyer; Alexander Gregorieff; Nuria Ruiz Roig; Fernando Vidal-Vanaclocha; Larsimont Denis; Rui Caetano Oliveira; Peter Metrakos; Dirk J Grünhagen; Iris D Nagtegaal; David G Mollevi; William R Jarnagin; Michael I D'Angelica; Andrew R Reynolds; Michail Doukas; Christine Desmedt; Luc Dirix
Journal:  Br J Cancer       Date:  2022-06-01       Impact factor: 9.075

2.  Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.

Authors:  Yutaka Kurebayashi; Colleen P Olkowski; Kelly C Lane; Olga V Vasalatiy; Biying C Xu; Ryuhei Okada; Aki Furusawa; Peter L Choyke; Hisataka Kobayashi; Noriko Sato
Journal:  Cancer Res       Date:  2021-02-11       Impact factor: 13.312

Review 3.  The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns.

Authors:  Gemma Garcia-Vicién; Artur Mezheyeuski; María Bañuls; Núria Ruiz-Roig; David G Molleví
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

4.  LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme.

Authors:  Ming Lei; Xinghua Du; Xiaokai Li; Fuke Wang; Ling Gu; Feng Guo
Journal:  Open Life Sci       Date:  2022-02-11       Impact factor: 0.938

5.  Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgery.

Authors:  Masashi Utsumi; Masaru Inagaki; Koji Kitada; Naoyuki Tokunaga; Midori Kondo; Yuya Sakurai; Kosuke Yunoki; Ryosuke Hamano; Hideaki Miyasou; Yousuke Tsunemitsu; Shinya Otsuka
Journal:  Ann Surg Treat Res       Date:  2022-08-05       Impact factor: 1.766

6.  Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma.

Authors:  Linping Xu; Meimei Yan; Jianpeng Long; Mengmeng Liu; Hui Yang; Wei Li
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

Review 7.  Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment.

Authors:  Alessandro Granito; Luigi Muratori; Claudine Lalanne; Chiara Quarneti; Silvia Ferri; Marcello Guidi; Marco Lenzi; Paolo Muratori
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

Review 8.  The Endless Sources of Hepatocellular Carcinoma Heterogeneity.

Authors:  Marina Barcena-Varela; Amaia Lujambio
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 9.  Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.

Authors:  Claudia Sirbe; Gelu Simu; Iulia Szabo; Alina Grama; Tudor Lucian Pop
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.